Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trevogrumab in Sarcopenia
NCT01963598Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Nov 2013
- Primary completion
- Jan 2015
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of trevogrumab in Sarcopenia, sponsored by Regeneron Pharmaceuticals. Started Nov 2013; status: completed.
02
Drugs
trevogrumab
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT01963598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963598.